Enliven Therapeutics, Inc. · NASDAQ:ELVN

Polar Capital Holdings Plc reported a 8.46% stake in Enliven Therapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 15, 2026

Polar Capital Holdings Plc reported a 8.46% stake in Enliven Therapeutics, Inc., 5,056,807 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).

Stake
8.46%
Shares
5,056,807
Intent
Passive
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
Polar Capital Holdings Plc8.46%5,056,807
Polar Capital LLP8.46%5,056,807
Polar Capital Funds PLC - Biotechnology Fund8.46%5,056,807

Source

View original at SEC

Related